Alys Pharmaceuticals
PrivateLast Round
Seed
Feb 12, 2024
Total Funding Raised
$100M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alys Pharmaceuticals operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in February 2024.
Alys Pharmaceuticals is a biotechnology company that develops a pipeline of programs and platforms targeting multiple dermatological indications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alys Pharmaceuticals Comparables
Compare Alys Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dermaliq Therapeutics, Inc. | 81% | |
| DermBiont | 77% | |
| Ahammune Biosciences | 71% |
For institutional investors. Book with your work email.
Alys Pharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Alys Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Medicxi | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 75% MoM.
For institutional investors. Book with your work email.
Alys Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alys Pharmaceuticals's valuation, stock price, and market status.
Is Alys Pharmaceuticals a public or private company?
Alys Pharmaceuticals is a private company.
What is the current stock price of Alys Pharmaceuticals?
Alys Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Alys Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alys Pharmaceuticals worth (valuation)?
Valuation information for Alys Pharmaceuticals is not publicly available.
Can I buy Alys Pharmaceuticals stock?
Alys Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alys Pharmaceuticals's last funding round?
Alys Pharmaceuticals's most recent funding round was Seed on February 12, 2024.
Who are the main investors in Alys Pharmaceuticals?
Key investors in Alys Pharmaceuticals include Medicxi.
Will Alys Pharmaceuticals IPO soon?
No public IPO plans have been announced for Alys Pharmaceuticals.
How can I track Alys Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Alys Pharmaceuticals's shares on secondary markets.